[1] SIEGEL RL, MILLER KD, JEMAL A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7. doi: 10.3322/caac.21387
[2] MALUCCIO M, COVEY A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma[J]. CA Cancer J Clin, 2012, 62(6): 394. doi: 10.3322/caac.21161
[3] DONADON M, SOLBIATI L, DAWSON L, et al. Hepatocellular carcinoma: the role of interventional oncology[J]. Liver Cancer, 2016, 6(1): 34.
[4] GUTTMAN M, AMIT I, GARBER M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals[J]. Nature, 2009, 458(7235): 223. doi: 10.1038/nature07672
[5] LIU Z, WANG Y, WANG L, et al. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2019, 38(1): 194. doi: 10.1186/s13046-019-1188-x
[6] SUN L, WANG L, CHEN T, et al. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells[J]. Cell Death Dis, 2020, 11(2): 95. doi: 10.1038/s41419-020-2274-x
[7] DU W, FENG Z, SUN Q. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway[J]. Biochem Biophys Res Commun, 2018, 507(1/4): 198.
[8] ZhANG Y, HUANG Z, SHENG F, et al. MYC upregulated LINC00319 promotes human acute myeloid leukemia(AML) cells growth through stabilizing SIRT6[J]. Biochem Biophys Res Commun, 2019, 509(1): 314. doi: 10.1016/j.bbrc.2018.12.133
[9] ZOU J, WU K, LIN C, et al. LINC00319 acts as a microRNA-335-5p sponge to accelerate tumor growth and metastasis in gastric cancer by upregulating ADCY3[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 318(1): G10. doi: 10.1152/ajpgi.00405.2018
[10] ZHOU B, YUAN W, LI X. Long intergenic noncoding RNA 319(linc00319) promotes cell proliferation and invasion in lung cancer cells by directly downregulating the tumor suppressor MiR-32[J]. Oncol Res, 2017. doi: 10.3727/096504017X15016337254650.
[11] YANG J, HOU S, LIANG B. LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis[J]. In Vitro Cell Dev Biol Anim, 2020, 56(2): 145. doi: 10.1007/s11626-019-00425-5
[12] PONTING CP, OLIVER PL, REIK W. Evolution and functions of long noncoding RNAs[J]. Cell, 2009, 136(4): 629. doi: 10.1016/j.cell.2009.02.006
[13] WANG Y, LIU Z, YAO B, et al. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis[J]. Mol Cancer, 2017, 16(1): 123. doi: 10.1186/s12943-017-0702-z
[14] SONG P, YIN SC. Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis[J]. Gene, 2019, 680: 51. doi: 10.1016/j.gene.2018.09.032
[15] YANG Y, ZHANG F, HUANG H, et al. Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis[J]. J Cell Physiol, 2020, 235(4): 3768. doi: 10.1002/jcp.29271
[16] LI Q, WU Q, LI Z, et al. LncRNA LINC00319 is associated with tumorigenesis and poor prognosis in glioma[J]. Eur J Pharmacol, 2019, 861: 172556. doi: 10.1016/j.ejphar.2019.172556
[17] ZHANG ZW, CHEN JJ, XIA SH, et al. Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2[J]. Gene, 2018, 650: 60. doi: 10.1016/j.gene.2018.01.096
[18] LI F, LIAO J, DUAN X, et al. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma[J]. J Cell Biochem, 2018, 119(12): 10393. doi: 10.1002/jcb.27388
[19] QI G, KONG W, MOU X, et al. A new method for excavating feature lncRNA in lung adenocarcinoma based on pathway crosstalk analysis[J]. J Cell Biochem, 2019, 120(6): 9034. doi: 10.1002/jcb.28177
[20] YANG J, WEINBERG RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis[J]. Dev Cell, 2008, 14(6): 818. doi: 10.1016/j.devcel.2008.05.009